Biotechnology Industry












Biotech Sector: Economic Outlook

According to Dr Clive James, Founder and President of the International Service for the Acquisition of Agri- Biotech Applications (ISAAA), the
period 2006-2015 has been projected as the "decade of Asia" in the field of biotechnology.

Achieving US$ 1 billion mark with export accounting for US$ 756 million is an important milestone for the Indian biotech sector. Biotech companies are earning huge profits and are using these profits for further investments, e.g. Wockhardt acquired Pinewood Laboratories and Reliance Life Sciences took staked control of GeneMedix Plc.
Some of the important points are:

  • BioAgri's share of exports reached to Rs 35.88 crore.
  • BioServices overseas revenues were Rs 684 crore.
  • Indian pharmaceutical industry is growing at the rate of over 8 per cent per year.
  • BioPharma exports amount to Rs 3,357.17 crore (74.33 percent of the total exports).
  • BioInformatics and BioIndustrial sector accounted for 3% and 1.23 % of the total exports respectively.
  • Ever-increasing investment levels (Rs 1,650 crore against Rs 1,215 crore previous year).
  • Investment of 25.3% of revenue in research and building infrastructure.
  • Western India is leading with revenues of Rs.3, 234.42 crore (49.6% of Indian biotech share).